Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing: A New Hope in Drug Discovery for Prostate Cancer
Jonaid Ahmad Malik, Sakeel Ahmed, Sadiya Sikandar Momin, et al.
ACS Omega (2022) Vol. 8, Iss. 1, pp. 56-73
Open Access | Times Cited: 17

Showing 17 citing articles:

Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment
Sonali Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 467-467
Open Access | Times Cited: 21
Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials
Ignatios Ioakeim‐Skoufa, Natalia Tobajas-Ramos, Enrica Menditto, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2972-2972
Open Access | Times Cited: 14
Mechanism of Abnormal Activation of MEK1 Induced by Dehydroalanine Modification
Yue Zhao, Shanshan Du, Chaoyue Zhao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7482-7482
Open Access | Times Cited: 4
Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
Tânia Lourenço, Nuno Vale
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4154-4154
Open Access | Times Cited: 11
The evidence for repurposing anti-epileptic drugs to target cancer
Mir Aroosa, Jonaid Ahmad Malik, Sakeel Ahmed, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7667-7680
Open Access | Times Cited: 9
Informatics on Drug Repurposing for Breast Cancer
Hui Zhou, Hongdou Liu, Yan Yu, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1933-1943
Open Access | Times Cited: 8
The Application of Artificial Intelligence and Drug Repositioning for the Identification of Fibroblast Growth Factor Receptor Inhibitors: A Review
Parvin Zarei, Fahimeh Ghasemi
Advanced Biomedical Research (2024) Vol. 13
Open Access | Times Cited: 2
Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancer
Md. Ashiqur Rahman Ashik, Md. Arju Hossain, Sheikh Atikur Rahman, et al.
Informatics in Medicine Unlocked (2024) Vol. 47, pp. 101488-101488
Open Access | Times Cited: 2
Let’s Go 3D! New Generation of Models for Evaluating Drug Response and Resistance in Prostate Cancer
Tina Petrić, Maja Sabol
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5293-5293
Open Access | Times Cited: 5
Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells
Jowaher Alanazi, Onur Bender, Rumeysa Dogan, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5253-5253
Open Access | Times Cited: 2
Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine
Jeba Ajgar Ansari, Jonaid Ahmad Malik, Sakeel Ahmed, et al.
Pharmacology (2023) Vol. 108, Iss. 6, pp. 504-520
Open Access | Times Cited: 2
Widened Scope of Drug Repurposing/Chiral Switches, Elements of Secondary Pharmaceuticals: The Quinine/Quinidine Case
Ilaria D’Acquarica, Israel Agranat
Future Drug Discovery (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 2
The ethnomedicine, phytochemistry, and pharmacological properties of the genus Bersama: current review and future perspectives
Gashaw Nigussie, Sintayehu Ashenef, Asfaw Meresa
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Drug repurposing analysis with co-expressed genes identifies novel drugs and small molecules for bladder cancer
Esra Göv, Gökçe Kaynak Bayrak
Journal of Scientific Reports-A (2024), Iss. 056, pp. 70-81
Open Access
β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers
Pedro Braga, J. Vieira, Aline Rachel Bezerra Gurgel, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
CircTENM3 inhibites tumor progression via the miR-558/RUNX3 axis in prostate cancer
Lingxiang Lu, Fei Wang, Jianchun Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
George S. Q. Tan, Edoardo Botteri, Stephen Wood, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Page 1

Scroll to top